Yarrow Bioscience, Inc. (YARW) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Yarrow Bioscience, Inc. (YARW) closed at USD 18.90 on 2026-10-14, a change of +90.2 % over the past year, with a market capitalization of USD 186.09M.

Yarrow Bioscience, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Yarrow Bioscience, Inc. key figures

Previous close

USD 18.90 (2026-10-14)

1-year change

+90.2 %

Market cap

USD 186.09M

Enterprise value

USD 142.13M

P/E ratio (trailing)

n/a

P/E ratio (forward)

-12.12

EPS (trailing)

n/a

EPS (forward)

-1.65

PEG ratio

n/a

Price to book

-0.77

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

1.15

Employees

7

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Yarrow Bioscience, Inc.

Yarrow Bioscience, Inc. operates as a clinical-stage biotechnology company that engages in developing transformative therapies for autoimmune thyroid diseases. The company's candidate, YB-101, is a humanized monoclonal antibody targeting the thyroid-stimulating hormone receptor (TSHR) for the treatment of Graves' disease and thyroid eye disease. The company was incorporated in 2025 and is based in New York, New York.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Yarrow Bioscience, Inc. and compare it with other stocks.